Method and reagent for monitoring blood levels of antiplantelet compounds
US6150114A · kind A · utility
1Cited by
5References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 1997 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | May 15, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for determining the amount of an antiplatelet compound in a subject being treated with the compound which comprises calculating the ACT number of the subject's blood containing a reagent which immunoreacts with the antiplatelet compound and comparing the figure to a standardized concentration figure. In subjects concurrently being treated with heparin and antiplatelet compounds, the method can be practiced without additional heparin added to the blood sample. The invention also provides reagents which immunoreact with antiplatelet compounds and kits comprising immunoreactive reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.